Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy

Microbiota Clinical Trial

Official title: Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy

Status Recruiting

Clinical Trial Summary

To date, few studies have addressed the link between gut microbiota and breast cancer chemotherapy, and previous studies have only provided a link between the gut and breast cancer.

Clinical Trial Description

To date, few studies have addressed the link between gut microbiota and breast cancer chemotherapy, and previous studies have only provided a link between the gut and breast cancer.At present, studies on the interaction mechanism between intestinal flora and breast cancer mainly focus on two aspects: first, intestinal flora affects the occurrence and progress of breast cancer by affecting estrogen metabolism;Second, intestinal flora can influence the occurrence and treatment of breast cancer by affecting the regulation of the immune system.However, the specific types (or groups) of bacteria that promote the occurrence, development and mechanism of breast cancer still need to be further studied.In addition, since most of the current clinical studies on microorganisms and breast cancer are small sample studies, the accuracy of their conclusions remains to be studied. ;

Related Conditions & MeSH terms

• Breast Neoplasms
• Microbiota

• NCT number: NCT04138979
• Study type: Observational
• Source: First Affiliated Hospital of Harbin Medical University
• Contact: Yunwei Wei, doctor
• Phone: +86-0451-85553099
• Email: hydwyw11@hotmail.com
• Status: Recruiting
• Start date: September 12, 2019
• Completion date: October 15, 2020